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A developmental neurotoxicity study is used to
assess neurologic development in laboratory
animals following toxicant exposure. One
important component of this evaluation is
histopathology. Differences between species in
the rates and complexities of biologic processes
underlying neurologic development contribute
signiﬁcantly to the challenge of using an ani-
mal species, such as the rat, to predict the neu-
rotoxic potential of a chemical in humans.
Central to morphologic assessment of the
developing brain is knowing what to look for
and when to look. Corresponding time frames
of rat and human development for key events
in nervous system morphogenesis provide a
global spatial–temporal map that together with
an understanding of the pathogenesis of ner-
vous system malformations can guide the
pathologist in identifying and interpreting
treatment-related effects (1,2). Two considera-
tions are essential for identifying adverse
effects: First, regressive events essential to nor-
mal development such as programmed cell
death must be distinguished from treatment-
related effects that may exhibit similar mor-
phologic characteristics. Second, disruption of
relatively early developmental events can alter
growth and differentiation, thus producing
alterations in the size of neuroanatomic struc-
tures, even in the absence of evidence of cell
death or of associated tissue reaction.
Quantitative assessment of morphologic
parameters has been proposed as an important
measure in developmental neurotoxicity test-
ing (3). Given that few laboratories have had
experience in the performance of the
histopathology portion of developmental
neurotoxicity studies (especially the morpho-
metric components), we present an overview
of current procedures and related background
information. 
Practical Issues
Personnel Qualiﬁcations
Conduct of the neuropathology component
of a developmental neurotoxicity study
requires special training for the pathologist
and technical staff. The study pathologist
should be experienced in neuropathology and
should have sufficient knowledge of neu-
roanatomy to be able to recognize histologic
sections for consistency of level and orienta-
tion. For example, the pathologist should be
able to recognize readily whether a nonhomol-
ogous section represents a level anterior or
posterior to the desired plane and should also
be able to determine whether nonstandard
sections should be measured or excluded from
the morphometry data set. The pathologist
should also have some knowledge of func-
tional neuroanatomy and of the major neuro-
transmitter circuits. Finally, the pathologist
should have sufficient experience examining
developing rat brains to be able to recognize
those normal regressive processes (e.g., pro-
grammed cell death) that might be miscon-
strued as pathologic. The technical staff
should also have some knowledge of gross
neuroanatomy. For example, prosectors must
be able to recognize the neuroanatomic land-
marks used for standardized slicing of brains.
Furthermore, both prosectors and histo-
technicians should be able to determine by
gross examination which face of a brain slice
is anterior and which is posterior, in the event
that these slices flip over during slicing or
processing. Finally, because slight deviations
from standard procedures may have signifi-
cant effects on the outcome of a study, all
prosectors and histotechnicians should be
meticulous in their attention to detail. 
Ages and Numbers of Examined Rats
Various guidelines may require the examina-
tion of brains from postnatal day (PND) 11
or PND22 rats, as well as the brains of young
adult rats (usually PND60) (4,5). Note that
methods of classifying rat ages vary from lab-
oratory to laboratory. The first 24 hr after
pairing of the adult male and female rat may
be classified as embryonic day (E) 0, or E1,
depending on the laboratory. Similarly, the
day of birth may be considered PND0 or
PND1. Selection of the most appropriate
sampling times may relate to both the dura-
tion of exposure and the milestones of neu-
roanatomic development. Regardless of the
provisions of the specific test guidelines, the
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most appropriate sampling time may be
guided by knowledge of the potential for the
chemical to interact with the brain during
certain critical points or phases in its develop-
ment (6). Distinct populations of neurons
have relatively speciﬁc “birth dates” (7,8). For
example, mitotic activity is still present
within the external germinal (granular) layer
of the cerebellum at PND11 as well as within
the dentate gyrus of the hippocampus.
Cessation of mitotic activity does not occur
in the rat brain until PND16 (9). By PND21
the rat brain is essentially in its adult form,
even though poorly myelinated and not of
adult size. Therefore, examination of rat
brains at PND21 may not necessarily have a
significant advantage over examination of
adult rat brains. 
Although six animals per sex and treatment
group have frequently been used for these
studies, this number may be too limited for
morphometric evaluations of PND11 rats
because of the rapid growth that the rat brain
is undergoing at this stage. A group size of 10
rats/sex has been found to be more appropriate
by one of the authors (RHG) based on per-
sonal experience and data power analysis. Even
if the group size is increased over that recom-
mended by current guidelines, brains from
additional rats should be saved in fixative in
case some brains are traumatized during
removal and thus may need to be excluded
from evaluation. In some situations, it may
also be desirable to increase the group size to
measure structures in different section planes
or in different orientations (e.g., sagittal rather
than coronal) or to perform morphometry by
more than one technique.
Tissue Fixation and Handling 
Perfusion ﬁxation should be employed for the
adult (PND60) rats, whereas immersion ﬁxa-
tion is usually adequate for the juvenile
(PND11) rats. The calvaria should be
removed from the nonperfused PND11 rats
at the time of necropsy and the brains subse-
quently ﬁxed in situ to minimize artifact. The
brains of PND11 rats are very soft, however,
and are easily traumatized during removal of
the calvaria. 
Brain weights for both juvenile and adult
rats should be taken postfixation. In remov-
ing brains for weighing and subsequent dis-
section, it is important to keep the olfactory
bulbs intact and also to standardize the level
at which the medulla is transected. The
medulla is usually cut just posterior to the
occiput (i.e., just anterior to the atlas).
Because ﬁxation represents a chemical process
that takes at least several hours, perfusion-
ﬁxed PND60 rat brains should be left in situ
for additional immersion ﬁxation rather than
being removed immediately after perfusion.
The ﬁxative to be used and the length of time
that tissues are held in fixative may be
dictated by anticipated histologic procedures,
such as those involving special stains. For
example, the staining quality of many
immunoperoxidase stains is adversely affected
by prolonged ﬁxation or by ﬁxation in certain
ﬁxatives such as Bouin’s. For a more detailed
discussion of neuropathology techniques, see
Fix and Garman (10). 
PND11 rat brains have high water content
and are nonmyelinated. Therefore, they are
very soft and easily traumatized. Some
anatomic structures that might be used as
gross dissection guidelines, such as the optic
chiasm, are difﬁcult to visualize at this young
age. The cerebellum of PND11 brains is
incompletely formed, making it difficult to
achieve highly standardized coronal sections of
this structure. Standardized sagittal sections of
the cerebella (or the entire brain) may be eas-
ier to obtain. Use of magniﬁcation will aid in
identifying neuroanatomic landmarks on
PND11 rat brains. Brains of rats at PND11
will be characterized by greater variations in
size than brains from older or adult rats due to
rapid growth of the brains at this stage cou-
pled with slight variations (in hours) in length
of gestation and preculling of litter size
(Figure 1). 
Brains from juvenile rats may be placed in
Bouin’s fixative to enhance their firmness,
although ﬁxation in Bouin’s will cause brain
shrinkage and should be controlled carefully.
For example, experience (in the ﬁrst author’s
laboratory) using Bouin’s ﬁxative after forma-
lin fixation caused approximately 23%
decrease in brain weight and 7% decrease in
anterior-to-posterior brain length measure-
ment for PND12 rats. If brains are placed in
Bouin’s ﬁxative before formalin ﬁxation, they
should be transferred through at least two
changes of alcohol and then placed in forma-
lin. Brains should not be left in alcohol solu-
tions because this may induce myelin
vacuolation (11–13). The dehydration times
on the tissue processor must be shorter for the
PND11 rat brains than for adult rat brains;
otherwise, the PND11 brain slices may
become excessively dehydrated. 
Nervous system tissues from representative
numbers of animals from each of the control
and high-dose treatment groups are examined
microscopically in most studies [e.g., (4,14)].
If treatment-related microscopic changes or
intergroup morphometric differences are
noted, additional evaluations are then per-
formed on tissues from the other treatment
groups. Animal tissues from the intermediate
and low-dose treatment groups are generally
held in formalin, and if morphometric evalua-
tions are to be performed one must consider
the potential effects of long-term formalin ﬁx-
ation on tissue volume. Evidence shows that
prolonged formalin fixation may enhance
brain shrinkage (15,16) and that brain
shrinkage can result from parafﬁn embedding
(17). Therefore, to ensure consistency, brain
slices should be prepared, processed, and
embedded at approximately the same time for
all animals on which morphometric evalua-
tions may be performed. Representative num-
bers of brains from both control and treated
animals also should be processed in the same
batch to prevent intergroup differences in
shrinkage related to the freshness of the alco-
hols and paraffin solvent solutions in the
processor.
Dissection Procedures for Brains
Pathologists may prefer to evaluate coronal
(transverse) sections of rat brains because this
orientation is most familiar to them; however,
sagittal sections may be most appropriate for
tracing brain stem neural pathways or for
measuring distances between certain subcorti-
cal anatomic structures. Additionally,
anterior-to-posterior dimensions for certain
structures, such as the developing cerebellar
cortex, may be quite important. Anterior–
posterior (AP) measurements of the cerebrum
and cerebellum may be obtained from intact
brains with a Vernier caliper before slicing the
brain if coronal slices are to be prepared.
Brain widths and heights may also be taken
with a Vernier caliper before slicing.
However, these dimensions are less critical to
obtain on the whole brain because they can
be obtained subsequently from the tissue sec-
tions. Some pathologists may prefer to per-
form a mid-sagittal section through the
cerebellum rather than standardized coronal
sections through various levels of the cere-
brum and brainstem. If a sagittal section is to
be taken of the cerebellum, the width mea-
surement of the cerebellum (rather than its
AP dimension) might be obtained with a
Vernier caliper before brain slicing.
Brain matrix molds/miter boxes may be
helpful for obtaining vertical slices of even
thickness. However, these molds are of lim-
ited value for obtaining homologous sections
from either adult or juvenile rat brains.
Figure 1. Gross photo of three control group PND11
Sprague-Dawley rat brains showing the degree of brain
size variation that may be encountered at this age.
(There were 20 rats in this group.) 
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Multiple molds would be required because
brain size varies at PND11 (Figure 1), and
these molds may traumatize the PND11
brains during slicing. Even when the molds
are of the correct size (e.g., for adults), the
knife grooves in the molds may not line up
correctly with the desired gross anatomic
structures. Sections from these molds there-
fore will not be as standardized as those
obtained by using specific neuroanatomic
landmarks as guides. However, free slicing of
brains outside of a mold requires practice and
experience. Placing a mirror on the opposite
side of the brain may assist in keeping the
knife axis perpendicular to the long axis of
the brain. The same individual should slice all
of the brains on a study for a particular sex
and age of rat to ensure consistency. Encasing
each brain in an agar medium as described by
Duffell et al. (18) is an alternative technique
that may help some prosectors achieve paral-
lel vertical cuts. On the other hand, the agar
may make it more difﬁcult to see some of the
small gross neuroanatomic landmarks present
on PND11 rat brains. The prosector should
understand that “facing in” of the tissue
blocks by the histology technician will cause
some tissue loss. Each gross cut made in the
brain, therefore, should be slightly anterior to
the desired level (assuming that the anterior
face of the slice is the one to be sectioned).
Brain blocks also must be sectioned in a
highly standardized manner. Generally, the
initial full-face section is obtained from the
block, after which multiple step sections are
prepared (at least two or three step sections
initially), sectioning deeper into the block as
necessary. The histotechnician must recog-
nize the desired tissue level by observing the
sections as they ﬂoat out on the water bath or
by looking at unstained sections under the
microscope. Furthermore, embedding must
be performed in a highly standardized man-
ner and the plane of sectioning must not be
changed. Most of the useful anatomic land-
marks for guiding dissection are present on
the ventral aspect of the brain, except the
cerebellum. Specific neuroanatomic land-
marks for brain slicing may include structures
such as the optic chiasm, the infundibulum,
and the mammillary body. Note, however,
that the level of the optic chiasm may vary
signiﬁcantly between rats, particularly in juve-
nile animals. The measured sections must be
homologous among individual rats when lin-
ear measurements are performed to satisfy the
morphometry component of a developmental
neurotoxicity study. In contrast, certain pro-
cedures may call for randomly selected sec-
tions (see discussion under “Morphometry”). 
Histologic Stains 
Special morphologic staining procedures can
and should be considered for use in
developmental neurotoxicity studies. The
addition of special histochemical or
immunocytochemical procedures is scientiﬁ-
cally necessary in many cases to adequately
identify and characterize toxicant-related
effects. Special approaches may provide
additional information about morphologic
changes detected on standard slides stained
with hematoxylin and eosin or may allow
the pathologist to detect effects not readily
evident in these slides. Although special
stains are not required under current regula-
tions (4), some guidelines suggest that both
myelin stains and silver stains be performed
on the adult rats (14). 
Various special stains traditionally have
been used to evaluate nervous tissue compo-
nents. Procedures for these can be found in
general reference texts on histology methods
(19–21). Further, newer methodologies are
emerging from the neuroscience literature,
and a selection of these is represented in Table
1. Any of these stains might be applied and
appropriately interpreted in developmental
neurotoxicity studies, although the immature
brain does not have a mature complement of
structures stained by these procedures. As a
result, the characteristics of a particular
stain will vary, depending on the age of the
animal. Most of the special stains presented
in Table 1 are appropriate for paraffin-
embedded tissues, but some (such as the
black-gold stain and some silver degenera-
tion stains) are used best on either frozen or
vibratome sections.
The literature is fairly limited, unfortu-
nately, on the application of special staining
procedures in the evaluation of developmen-
tal brain injury induced by neurotoxicants.
Study reports that do exist typically lack a
period of gestational exposure and vary from
study to study regarding the dosage regimen,
i.e., the age of initial exposure and length of
treatment. Many approaches are available to
characterize aspects of developmental neuro-
biology, but these methods have not been
used widely to study the effects of neurotoxi-
cants on developmental processes.
Stains for Neurons and Myelin
The cresyl echt violet (Nissl) stain demon-
strates many details in the nerve cell body,
particularly in larger neurons. This technique
stains all nuclei in the section (neurons plus
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Table 1. Special stains and ancillary procedures for consideration in developmental neurotoxicity studies.
Tissue component Procedure Comments References
Neuron
Cell body Cresyl echt violet Stains perinuclear  Luna, 1968a (19)
Nissl substance in larger  Sheehan and Hrapchak, 1980a (20) 
neurons; good stain for Carson, 1997a (21)
overall cellularity
Myelin sheath Luxol fast blue Good differentiation of  Luna, 1968 (19)
gray and white matter;  Sheehan and Hrapchak, 1980 (20)
not useful in very Carson, 1997 (21)
young animals Schmued and Slikker, 1999b (85)
Black gold
Axons (nerve ﬁbers) Standard silver stains Stains most axons Luna, 1968 (19)
(Bodian, Holmes, Sevier- Sheehan and Hrapchak, 1980 (20)
Munger, Bielschowsky) Carson, 1997 (21)
Degenerating cell  Silver degeneration  Selectively stains Yamamoto et al., 1986 (22)
bodies, axons,  stains (cupric-silver  degenerating neurons;  Beltramino et al., 1993a (23)
nerve terminals,  procedure) can identify apoptotic  Fix et al., 1996b (26)
and dendrites cells during early  Switzer, 2000a (24)
postnatal life Ikonomidou et al., 2000 (27,28)
Schmued et al., 1997, 2000b (86,87)
Neurotransmitters  Neurochemistry or May provide topographic Virgili et al., 1990 (33)
and neuron-speciﬁc  immunohistochemistry orientation to other Axt and Molliver, 1991b (34)
proteins biochemical data Kalia et al., 2000b (35)
Astrocytes Immunohistochemistry Increases in GFAP content Goodlett et al., 1993 (44)
for GFAP occur in association with Freeman et al., 1994 (47)
the astrocytic hypertrophy Harry et al., 1996 (48)
Microglia Lectin histochemistry Detects morphologic Morioka and Streit, 1991 (54)
transformation from the  Fix et al., 1996 (26)
resting to phagocytic state
Immunohistochemistry Upregulation of immuno- Milligan et al., 1991 (51)
for MHCs and  logic antigens may occur  Morioka and Streit, 1991 (54)
complement receptors before morphologic  Wilson and Molliver, 1994b (50)
transformation to the  McRae et al., 1995 (52)
phagocytic state  Ohno et al., 1995 (53)
GFAP, glial ﬁbrillary acidic protein. aReview article or text. bDoes not speciﬁcally address neonatal development. 
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all others) and is therefore useful as an
indicator of overall cellularity. In addition,
this stain highlights the intensely basophilic
endoplasmic reticulum (Nissl substance) in
the perinuclear cytoplasm of larger neurons.
Loss of Nissl staining can be associated with
damage to the axon, particularly as seen with
various types of physical injury. Cresyl echt
violet staining may be combined with a
myelin stain such as luxol fast blue in one
procedure (19–21). 
Luxol fast blue stain reacts with lipo-
proteins that are heavily concentrated in
myelin, providing delineation of the periax-
onal myelin sheath. This stain provides excel-
lent histologic differentiation between gray
and white matter and is often a good stain
for morphometric evaluations in some tech-
niques. Myelination is actively ongoing dur-
ing the postnatal period. Therefore, stains
that identify myelin layers around axons will
not appear as intense in juvenile rats until
myelination is complete. Little or no central
myelin is present within the brains of
PND11 rats, so a myelin stain is not very
useful at this stage. A myelin stain combined
with a nuclear stain for cellularity, such as
Nissl, may still be useful in the evaluation of
neonatal rat brains. 
Standard silver stains can be used to
identify axons and some dendrites in tissue
sections, whereas silver degeneration stains
selectively bind to degenerating neurons.
Standard silver methods stain both normal
and degenerating nerve processes and require
careful comparison between treated and con-
trol animal tissues for interpretation of
effects. The staining principle is based on the
impregnation of the nerve ﬁber by silver ions,
which are then chemically reduced to visible
metallic silver. There are several silver staining
procedures named for those who developed
them, including Bodian, Holmes, Sevier-
Munger, and Bielschowsky (19–21). 
Silver degeneration stains are a modiﬁcation
of the standard silver staining procedures
mentioned above, but they have the ability to
selectively stain degenerating components of
injured neurons. In contrast to standard silver
stains, which primarily reveal larger-sized
neuronal processes such as axons, silver
degeneration stains can potentially delineate
degenerative effects within any portion of the
entire neuron, i.e., dendrites, cell body,
axons, and nerve terminals. These procedures
have been used for the identiﬁcation of apop-
totic neurons during the early postnatal
period (22) as well as for neurotoxicity evalu-
ations (23,24). To date, silver degeneration
stains have been applied mostly in adult neu-
rotoxicity studies (25,26), but their potential
for adding to the understanding of develop-
mental neurotoxicity is beginning to be
explored. For example, silver degeneration
stains have been used recently to show that
ethanol and other drugs that antagonize the
N-methyl-D-aspartate receptor (the major
excitatory receptor in the brain) dramatically
increase the rate of apoptosis during the early
postnatal period in rat pups (27,28). These
new data support the emerging use of silver
degeneration stains for developmental neuro-
toxicity studies. 
Stains for Neurotransmitters and
Neuron-Speciﬁc Protein Markers
Immunohistochemical staining techniques for
speciﬁc brain neurotransmitters could be con-
sidered for use in developmental neurotoxicity
studies, and several atlases are available to assist
in understanding the regional distribution of
these neurotransmitters in the adult rat brain
(29–32). Investigation has shown that neuro-
transmitter system maturation tends to parallel
the general establishment of functional activity
in the brain during the process of synaptogene-
sis (33). In a strict sense, staining for changes
in speciﬁc neurotransmitters is a biochemical
not morphologic approach, and therefore may
be most useful for further characterizing effects
found with other morphometric procedures
rather than as an initial procedure. In addition,
neurotransmitter immunohistochemistry may
augment the interpretation of other bio-
chemical data. This approach has been applied
to neurotoxicity evaluations that characterize
the loss of serotonin immunoreactivity in
adult rats after treatment with drugs known
to act on this neurotransmitter system
(34,35). These studies have shown not only
the loss of serotonin immunoreactivity but
also changes in the morphologic appearance of
the serotonin nerve terminal network.
Application of this approach should be per-
formed in a topographically restricted manner
because the time course of neurochemical sys-
tem maturation varies in different brain regions
because of the diversity of cell populations and
differential growth (33).
Biochemical methods have been used in
developmental neurotoxicity studies to assess
levels of neurochemicals, including neuron-
specific protein makers. Levels of neuronal
proteins such as synaptophysin, neuro-
ﬁlament, and myelin basic protein have been
shown in these assays to change in response
to administration of various neurotoxicants
during the developmental period (36–40).
Development and use of immunohisto-
chemical procedures to detect these or other
similar neuronal protein markers might aug-
ment biochemical assessments and provide
information on topographic aspects of toxi-
cant effects on nervous system development.
Stains for Astrocytes
Astrocytes have been known for years as
major glial cells in the brain with important
physiologic and supportive activities (41).
These cells undergo hypertrophy and pro-
duce more glial fibrillary acidic protein
(GFAP), an astrocyte-specific intermediate
ﬁlament marker, in response to injury. Many
researchers consider an increased level of
GFAP a definitive marker of brain injury,
including damage induced by neurotoxi-
cants. GFAP content can be evaluated bio-
chemically or immunohistochemically in
tissue sections (26,42,43). Enzyme-linked
immunosorbent assays for GFAP performed
in developmental neurotoxicity studies have
revealed alterations in GFAP content in
response to such neurotoxicants as poly-
chlorinated biphenyls, methylmercury,
methylazoxymethanol, 6-hydroxydopamine,
tributyltin, and triethyltin (37–46). Given
this information, it is reasonable to use
GFAP immunohistochemistry as an indica-
tor of injury in the developing rat brain.
Developmental neurotoxicity studies with
ethanol, triethyltin, and lead have also used
GFAP immunohistochemistry to demon-
strate alterations in the timing of astrocyte
differentiation, as well as increases and/or
decreases in GFAP immunoreactivity
(44,47,48). When conducting developmen-
tal neurotoxicity studies with altered levels of
GFAP as an end point, one must consider
several aspects of GFAP biology. The GFAP
content of astrocytes varies considerably in
different brain regions, with levels lower in
gray matter and higher in white matter. In
addition, GFAP is developmentally regulated
during the early postnatal period, with
mRNA levels increasing from birth to
PND15 and declining to adult levels by
PND25 (48). 
Stains for Microglia
The cells in the brain with primary immuno-
logic and phagocytic roles are the microglia.
These cells can be demonstrated with a vari-
ety of histologic and histochemical techniques
(49). In the adult brain, microglia exist as
small resting cells with highly ramified
processes extending from a central nucleus.
Microglia are activated in response to injury.
When activated, they increase their expres-
sion of various immunologic molecules [e.g.,
major histocompatibility antigens (MHCs),
complement receptors] and transform mor-
phologically to a phagocytic phenotype.
Cytokine production and antigen presenta-
tion are associated with this activation and
transformation. Changes in microglial mor-
phology and immunology correlate with neu-
rotoxicity in adult rats (26,50). The nature of
these glial reactions may vary with different
injurious stimuli. 
There are sufficient data on adult rat
brains to consider morphologic and immuno-
logic changes in microglia reasonable markers
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for detecting injury in the developing brain.
However, several aspects of microglial biology
dictate caution in uniformly applying
approaches used on adult rat brains to juve-
nile brains. In contrast to the resting state in
adults, microglia are normally more physio-
logically active during the early postnatal
period when the brain is developing. This
heightened level of activity is probably related
to the profound loss of neurons that accom-
panies normal development. Evidence shows
that the origin of the macrophages respond-
ing to injury in juvenile brains differs from
the origin of the resting microglia known to
respond in adults in models of central ner-
vous system (CNS) trauma (51). Changes in
juvenile brain microglia seen using proce-
dures developed for study of adult brain cells
should therefore be interpreted carefully.
Nevertheless, studies have shown increased
expression of immunologic markers by
microglia in various neonatal injury models
(52,53). Microglia located in the CNS of
neonatal rats are activated by retrograde
motor neuron death in response to experi-
mental sciatic nerve crush and undergo mor-
phologic transformation while increasing
expression of MHCs (54).
Morphometry 
Neurotoxic chemicals that affect brain devel-
opment by interfering with DNA synthesis or
by inhibiting or delaying migration of neu-
rons or glial cells have the potential to reduce
the numbers of cells present in a variety of
neuroanatomic regions and, therefore, the
sizes of these regions. A size difference for a
particular brain region may be the primary
toxicant-related microscopic observation, and
for this reason some form of morphometric
analysis usually is conducted in developmen-
tal neurotoxicity studies. Basically, there are
three types of morphometric data: linear mea-
surements, areal measurements, and cell pro-
ﬁle counts. Stereology refers to the estimation
of the size of a three-dimensional object by
taking multiple measurements in two-dimen-
sional planes. Optical dissector stereology, on
the other hand, is a technique for estimating
the total numbers of cells within a volume of
tissue by performing counts of cell profiles
within multiple levels of the structure exam-
ined. Although optical dissector stereology
may be the most sensitive technique for
detecting and quantifying certain types of
neurotoxic end points, it is also the most
time-consuming methodology. Linear or areal
measures are more rapidly obtained. 
Taking linear measurements using a
calibrated ocular micrometer is the least time-
consuming morphometric method, thus
allowing numerous areas of the brain to be
measured cost-effectively. Furthermore, linear
morphometry can be performed on routinely
processed paraffin-embedded tissue sections
(i.e., the same sections as would be used for
the histopathologic evaluations). Linear mor-
phometry is particularly useful for quantifying
spatial relationships between neuroanatomic
structures as well as for measuring the thick-
nesses of cell layers. For some examples of the
use of linear morphometric measurement to
determine neurotoxic end points, see the work
of Rodier and coworkers (55,56). 
Linear measurement is the most cost-
effective approach to acquiring morphometric
data, but some authors have contended that
linear measurements lack sensitivity because
of inherent variability in tissue sections (e.g.,
oblique sections, sectioning artifacts) and
variations in the levels of the anatomic loca-
tions measured on the slides (17). Brain sec-
tions used for linear measurements must be
highly homologous among animals on a
given study to have predictive value.
Particular attention must be paid not only to
the gross neuroanatomic landmarks but also
to the angle at which the knife is held when
the slices are made during gross dissection.
The cuts for each brain slice must be made in
a vertical and parallel manner. Some degree
of step sectioning also will be required during
microtomy even if standard neuroanatomic
landmarks are used to determine the points
where the brains are to be sliced. 
The approach to the morphometric
evaluation may very well be directed by in-
life neurobehavioral alterations, by brain
weight differences, or by the results of the
microscopic evaluations. If there is no evi-
dence within a particular study of any in-life
neurobehavioral or neurologic findings, no
treatment-related differences in brain
weights, and no microscopic alterations, a
minimal approach would be to measure
those areas specified in the current U.S.
Environmental Protection Agency (U.S.
EPA) guidelines (4). These guidelines call for
an estimation of the thickness of major layers
at representative locations within the neocor-
tex, hippocampus, and cerebellum. Linear
measurements usually are taken bilaterally
and recorded separately, even if mean values
for the right- and left-sided measurements
are used for statistical analysis. Measuring
structures such as cortical thickness bilater-
ally can provide some information on the
symmetrical nature of the section. If knowl-
edge of the toxicant’s properties suggests that
it may have affected speciﬁc neuron popula-
tions or neurotransmitter pathways, measure-
ments of these potentially affected areas
should also be taken. Increased attention
should be given to those neuroanatomic
regions populated by cells generated on or
shortly after the days of treatment in situa-
tions where the toxicant was administered
only on speciﬁc gestational days. 
A certain degree of subjectivity is involved
in deciding the boundaries of individual neu-
roanatomic regions and the exact start and
end points of a linear measurement. It is
important, therefore, to use a level of magni-
ﬁcation that will provide a reasonable degree
of resolution. The best resolution will be
achieved with a microscope ﬁtted with a cali-
brated ocular micrometer. The disadvantage
of this approach is there are no resulting
images that include the exact location of the
linear measures taken. Although it may not
be necessary to have a visual display of every
linear measurement taken, it is highly advan-
tageous to have images of the measured sec-
tions included within the raw data. To
demonstrate section homology, these images
should be taken at a sufﬁciently low magniﬁ-
cation to allow a reviewer to establish the
level of the section. These images should also
be taken at a standardized magniﬁcation with
sufﬁcient information provided in the report
or raw data to allow a reviewer to repeat the
measurements directly on the images. The
degree of standardization of section level can
thus be established by a peer reviewer without
the need to reexamine the glass slides. Images
digitized and archived on a CD can then be
viewed on a monitor, printed to hard copy,
or subjected to additional analysis without
the need to reevaluate the original glass slides.
Whenever linear measurements are to be per-
formed directly on photographic prints
(either ﬁlm-based or digitized), controls must
be in place to ensure that the image magniﬁ-
cations are identical. Additionally, it is impor-
tant to note that the rotation of an image axis
in most computer software programs will
shrink the image. 
Various software programs are available
for performing linear or area measurements,
and one (Scion Image for either Windows or
Macintosh platforms; Scion Corp., Frederick,
MD) is available in the public domain (57).
Areal measurements may be taken from the
same sections used for the linear measure-
ments, and these sections may also be used
for the histopathologic evaluations. Image
analysis software packages provide the most
convenient method for performing areal mea-
surements, but other non-computer–based
approaches have been used for years (58). 
Linear and/or areal measurements may be
quite helpful for detecting certain develop-
mental neurotoxic end points; however, some
neuroanatomic regions are poorly demarcated
and are difﬁcult to measure by linear or areal
techniques. Optical dissector stereology may
be more sensitive for detecting certain types
of cell loss and reduces the need for highly
homologous sections. The reader is directed
to the literature for a more comprehensive
discussion of the principles of stereology
(59–68). The concept of randomly selected
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sections (which represents part of the
unbiased sampling concept) may confuse the
reader perusing the literature on optical dis-
sector stereology. The sections that are ran-
domly selected represent serial sections taken
through a particular neuroanatomic structure
rather than random sections taken through-
out the brain. Thus, one must still obtain rel-
atively homologous sections that pass through
the same level of a particular neuroanatomic
region. Stereology, sometimes called quantita-
tive histology, may be used to determine cell
numbers within a particular volume of tissue
and infer cell densities. Two-dimensional
counting of cell proﬁles, referred to as model-
based stereology, is based on certain assump-
tions about cell geometry. Three-dimensional
counting, or unbiased stereology, uses
random sampling procedures and the optical
dissector method and is thought not to require
such assumptions. The opinion has been
expressed, however, that unbiased neuronal
counting techniques may actually be biased by
sectioning artifacts seen in sections from tissues
embedded in either paraffin or glycol
methacrylate but not in frozen sections (69). 
The optical dissector method of unbiased
stereology uses a high numerical aperture
objective providing high magniﬁcation with a
narrow depth of field to count cell profiles
present in multiple optical planes within rela-
tively thick (20–50 µm) sections. Plastic-
embedded sections are generally 20–25 µm
thick, whereas thicker paraffin sections are
usually prepared to allow for subsequent
shrinkage resulting from parafﬁn removal and
subsequent staining. Optical dissection
requires a microscope with a stage calibrated
for movement along the z axis. Random sam-
pling involves a random or unbiased sampling
of section levels within a given neuroanatomic
region in the same tissue block of relatively
large neuroanatomic areas. Multiple serial sec-
tions are prepared through the neuroanatomic
area to be enumerated. The ﬁrst section to be
examined in this series is randomly selected
and cells are counted within a given number
of ﬁelds in that section. Subsequently, other
slides in the series (e.g., every tenth section
after the first randomly selected section) are
similarly counted. Only those cells intersect-
ing the lines of a standardized grid or count-
ing frame are included in the total count;
therefore, only a relatively small number of
cells must be counted within the area of inter-
est on a particular slide. The numbers of cells
present within a given volume of tissue are
then calculated using mathematical formulas.
Stereologic procedures may be used to quan-
tify numbers of dead or degenerating cells, a
procedure that may be enhanced further by
the application of a variety of special stains
such as terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labeling, cupric
silver, or Fluoro-Jade (27,28). Stereology also
may be used to determine synaptic densities
(70). Various staining procedures can also
help enumerate other cell types such as
astrocytes or microglial cells through optical
dissector stereology (71). 
Stereology takes significantly more time
than linear or areal measurements. For exam-
ple, a pathologist can take a dozen linear mea-
surements with an ocular micrometer in
approximately 15 min. Performing unbiased
stereology on a dozen different areas of the
brain would require at least several hours.
Optical dissector methodology also uses rela-
tively thick serial sections, thus requiring the
use of extra animals (besides those used for
histopathologic evaluations) and incurring
additional histology costs. 
In summary, unbiased stereology allows
enumeration of cells and determination of
cellular densities, whereas linear and/or areal
measures provide only an indication of the
overall size of the measured area. The greater
time investment and the need for thick sec-
tions, however, make stereology recom-
mended as a second-tier procedure. Optical
dissector stereology procedures are likely the
most sensitive indicator of postmigrational
cell loss (e.g., neurotoxic insults in adult ani-
mals). However, linear measures may be as
sensitive as stereology for detecting treatment-
related differences following exposure to toxi-
cants that affect early cell proliferation or
migration. Regardless of the techniques used
for morphometric analysis in a developmental
neurotoxicity study, treatment-related alter-
ations within the developing brain may be
manifested as differences in the sizes of neu-
roanatomic structures or as alterations in cell
or synaptic densities. In contrast, the adult
brain may show degenerative or reactive
changes such as eosinophilic neurons, reactive
astrocytes, spongiosis, demyelination, or
increased numbers of microglial cells. 
Interpretation of Morphometry Data
The biologic significance of brain size
variation encountered at PND11 may be
difficult to interpret given the rapid brain
development occurring at this time. This is
confounded when treatment-related mor-
phometric variations are seen in PND11
brains but not in adult rat brains in the
same study. An additional concern is the
potential effect on brain size as a result of
maternal toxicity. Brain sparing refers to the
observation that brain weight is relatively
unaffected by changes in total body weight,
whereas changes in the weights of many
other organs tend to be proportional to
changes in body weight. Brain sparing is
typically seen in undernourished adult ani-
mals, whereas delayed brain development
and thus smaller brains are seen in juvenile
animals when caloric or nutrient restriction
occurs during early postnatal development
(72–76). Delays in rat brain development
are easily demonstrable in the brains of rats
from litters of different sizes, but are also
seen in situations of decreased lactation,
decreased maternal nutrition, or maternal
neglect. In fact, the brains of undernour-
ished pups may never achieve the develop-
mental level of those of control group or
optimally nourished rats. Differential sensi-
tivity in the degrees of retardation of brain
development may be expected from one
area of the brain to another. For example,
areas that mature after birth (e.g., cerebral
cortex, cerebellum, and hippocampus)
might be more affected by undernutrition
than might subcortical structures that
develop in utero. Subtle shifts in morpho-
metric dimensions may indicate the pres-
ence of a treatment-related effect on brain
development. However, one must consider
the possibility that this effect may stem
from nutrition rather than from develop-
mental neurotoxicity. Pair-feeding studies
may help differentiate the effects of under-
nutrition from those caused by a develop-
mental neurotoxicant (77).
Brain-to-body-weight ratios of under-
nourished pups are generally equal to or
slightly greater than ratios of adequately
nourished rat pups, although the amount of
milk present in a pup’s stomach may signiﬁ-
cantly inﬂuence measured body weight. Data
have not been published on brain-to-body-
weight ratios in developmental neurotoxicity
studies to determine whether alterations in
this ratio are predictive of neurotoxicity (i.e.,
vs. malnutrition). Nevertheless, we recom-
mend that brain-to-body-weight ratios be
recorded. 
Peripheral Nervous System
Morphologic assessment of the peripheral
nervous system of rats (peripheral nerves and
ganglia, spinal nerve roots, and possibly other
structures) is required under current U.S.
EPA regulatory guidelines for adult rats in
developmental neurotoxicity studies. Such
assessment is not required for juvenile rats,
even though peripheral nerves are easily acces-
sible in juvenile rats and their myelinated
nerve fibers traditionally have been used to
provide qualitative and quantitative histologic
data for diagnostic and investigative evalua-
tion (4,73). Routine evaluation of the periph-
eral nervous tissue of juvenile rats might add
important neurodevelopmental information
to that derived from study of the brain and
warrants further consideration. Evaluation of
properly prepared peripheral nerve tissue can
provide qualitative and quantitative develop-
mental data regarding axon size, axon num-
bers, and the relationship between the axons
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and supporting glia. Although some of this
information may be gleaned from the study
of sections of the CNS, the better histologic
visualization of individual myelin sheaths and
their associated axons within the peripheral
nerve endoneural matrix greatly enhances
such morphometric assessments. Peripheral
nerve assessment can provide a quantitative
morphologic reflection of the integrity of
complex developmental processes such as
neuronal growth, axonal guidance, develop-
ment and connection of nerve endings,
Schwann cell evolution, migration and axonal
association, and myelination (78,79). 
The current regulatory developmental
neurotoxicity guidelines call for histologic
assessment of sensory ganglia and of multiple
levels of peripheral nerve in perfusion-fixed
adult (PND60) rats (4,80). As noted above,
peripheral nerve from younger, nonperfused
animals can be evaluated similarly. The sci-
atic nerve in these animals is accessible and
can be fixed adequately by immersion (81).
The developmental state of this nerve at
PND11 and beyond is adequate for qualita-
tive and quantitative histopathology (78).
Quantitative evaluation of peripheral nerve
tissue is enhanced by various computer-based
morphometry programs. These programs
assess data such as numbers and density of
myelinated fibers as well as axonal and
myelin area and perimeter, which can be
determined independently or relative to one
another (73). Studies using this approach
have revealed progressive increases in the cal-
iber of myelinated fibers over the 5–180
PND period in rats and can sometimes
detect subtle differences in fiber and axonal
diameter between control, dietary-restricted,
and restricted-rehabilitated rats (82,83).
The choice of tissue-embedding media is
an important consideration in peripheral
nerve pathology. Plastic-embedding proce-
dures are used for the peripheral nervous sys-
tem in adult rat neurotoxicity studies under
the U.S. EPA guidelines (18). In practice,
methacrylate or epoxy resin media have been
used to meet this requirement. A large num-
ber of peripheral nervous system tissues are
required in regulatory studies (i.e., Gasserian
ganglia, dorsal root ganglia, dorsal and ventral
spinal nerve roots, two levels of the sciatic
nerve, tibial nerve, and sural nerve), and
softer plastic media such as glycol metha-
crylate are often used for cost-effectiveness
(4,18,80). Embedding and sectioning tissues
in glycol methacrylate take less time than the
same procedures using epoxy media and also
enable processing of larger-sized pieces of
tissue. Glycol methacrylate sections provide
only a slightly greater level of light micro-
scopic resolution than does paraffin. The
denser epoxy resin plastics allow embedding
of nerve that has been postfixed in osmium
tetroxide, a process that enhances histologic
contrast (80). These tissue preparations can
be sectioned at approximately 1 µm thickness
and with appropriate stains provide the high
level of optical resolution needed for critical
histologic evaluation, including morphomet-
ric assessment of myelinated fibers (81).
Therefore, the use of epoxy resin for the
embedding media is desirable (80).
The usefulness of peripheral nervous
system tissue in histopathologic evaluations is
predicated on having appropriately fixed,
processed, and sectioned material. Perfusion
fixation is optimal, but immersion fixation
might be employed in some instances (80).
Epoxy resin–embedded nerve can also be used
for transmission electron microscopy with
appropriate fixation, such as glutaraldehyde
alone or in combination with paraformal-
dehyde. In addition, properly fixed tissue is
suitable for myelinated nerve fiber teasing,
allowing microscopic examination along a
proximal-distal gradient (73). Additional tis-
sues such as peripheral autonomic ganglia and
other nerve trunks are also available from
perfusion-fixed rats should the evaluation
need expansion.
Future Directions
The methods and techniques for pathologic
evaluation described here are valuable tools
used to assess morphologic alterations in the
developing nervous system. The increasing
resolution and availability of techniques such
as magnetic resonance imaging may soon pro-
vide a superior methodology for evaluating
treatment-related alterations in the brain
(84). New immunologic staining procedures
are being developed regularly; histologic
markers of neuronal or glial cell injury, as
well as of neurotransmitter levels, will likely
prove as vital to the pathologist in the evalua-
tion of these studies as the traditional stains
for myelin, glial cells, and nerve processes
currently in use. As both computer-imaging
programs and the specificity of stains
improve, analysis of patterns of dendritic
arborization and neurotransmitter localiza-
tion may become as important for evaluating
developmental neurotoxicant action as cur-
rent routine histopathologic evaluation.
Although our focus here is morphology, there
is tremendous potential for biochemical and
molecular biological techniques to comple-
ment current morphologic techniques.
Neuropathology will certainly continue to
change rapidly, and many of the new tech-
niques in investigative neurobiology will soon
ﬁnd their way into routine use. 
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